Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Protective Effects of 7,8-Dihydroxyflavone on Retinal Ganglion and RGC-5 Cells Against Excitotoxic and Oxidative Stress.
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.
A case of septal panniculitis secondary to interferon treatment.
Bayesian inferences for beta semiparametric-mixed models to analyze longitudinal neuroimaging data.
Uses of complementary and alternative medicine in multiple sclerosis.
Simvastatin: two decades in a circle.
Clonal Expansion of Mitochondrial DNA Deletions and the Progression of Multiple Sclerosis.
Pathology of Multiple Sclerosis.
Cortico-muscular coherence as an index of fatigue in multiple sclerosis.
Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis.
Natalizumab Therapy for Multiple Sclerosis.
The behavior-analytic origins of constraint-induced movement therapy: an example of behavioral neurorehabilitation.
AMPYRA® two-year safety data presented at 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Imaging new lesions: Enhancing our understanding of multiple sclerosis pathogenesis.
Do people with and without medical conditions respond similarly to the Short Health Anxiety Inventory? An assessment of differential item functioning using item response theory.
Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal study.
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.
Cognitive but not affective theory of mind deficits in mild relapsing-remitting multiple sclerosis.
Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease.
What do people with MS want from a web-based resource to encourage increased physical activity behaviour?
Generation and characterization of spiking and non-spiking oligodendroglial progenitor cells from embryonic stem cells.
Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS.
Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination.
Immunomodulatory properties of farnesoids: The new steroids?
Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients.

Pages